The Opioid Industry Documents Archive: A Living Digital Repository.
作者信息
Caleb Alexander G, Mix Lisa A, Choudhury Sayeed, Taketa Rachel, Tomori Cecília, Mooghali Maryam, Fan Anni, Mars Sarah, Ciccarone Dan, Patton Mark, Apollonio Dorie E, Schmidt Laura, Steinman Michael A, Greene Jeremy, Ling Pamela M, Seymour Anne K, Glantz Stanton, Tasker Kate
机构信息
At the time of the writing, G. Caleb Alexander, Lisa A. Mix, and Anni Fan were with the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Sayeed Choudhury and Mark Patton are with the Sheridan Libraries, Johns Hopkins University, Baltimore, MD. Rachel Taketa and Kate Tasker are with the University of California, San Francisco Library, San Francisco. Cecília Tomori is with the Johns Hopkins School of Nursing, Baltimore, MD. Maryam Mooghali is with the Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada. Sarah Mars and Dan Ciccarone are with the Department of Family and Community Medicine, University of California, San Francisco (UCSF). Dorie E. Apollonio is with the School of Pharmacy, UCSF. Laura Schmidt, Michael A. Steinman, Pamela M. Ling, and Stanton Glantz are with the School of Medicine, UCSF. Jeremy Greene is with the Johns Hopkins School of Medicine. Anne K. Seymour is with the Welch Libraries, Johns Hopkins University.
出版信息
Am J Public Health. 2022 Aug;112(8):1126-1129. doi: 10.2105/AJPH.2022.306951.
Abstract
摘要
相似文献
1
The Opioid Industry Documents Archive: A Living Digital Repository.阿片类药物行业文件档案库：一个动态的数字资料库。
Am J Public Health. 2022 Aug;112(8):1126-1129. doi: 10.2105/AJPH.2022.306951.
2
Erratum In: "The Opioid Industry Documents Archive: A Living Digital Repository".勘误：载于《阿片类药物行业文件档案：一个动态数字资料库》。
Am J Public Health. 2023 Jan;113(1):e1. doi: 10.2105/AJPH.2022.306951e.
3
How the Suboxone Education Programme presented as a solution to risks in the Canadian opioid crisis: a critical discourse analysis.《Suboxone 教育计划如何被呈现为解决加拿大阿片类药物危机中的风险的一种方案：批判性话语分析》。
BMJ Open. 2022 Jul 12;12(7):e059561. doi: 10.1136/bmjopen-2021-059561.
4
Marketing Opioids to Veterans and Older Adults: A Content Analysis of Internal Industry Documents Released from State of Oklahoma v. Purdue Pharma LP, et al.向退伍军人和老年人推销阿片类药物：从俄克拉荷马州诉普渡制药公司等案中发布的内部行业文件的内容分析
J Health Polit Policy Law. 2022 Aug 1;47(4):453-472. doi: 10.1215/03616878-9716712.
5
"My Surgical Success": Effect of a Digital Behavioral Pain Medicine Intervention on Time to Opioid Cessation After Breast Cancer Surgery-A Pilot Randomized Controlled Clinical Trial.《我的手术成功了》：数字化行为疼痛医学干预对乳腺癌手术后停止使用阿片类药物时间的影响——一项先导随机对照临床试验。
Pain Med. 2019 Nov 1;20(11):2228-2237. doi: 10.1093/pm/pnz094.
6
Designing Safer Analgesics via μ-Opioid Receptor Pathways.通过μ-阿片受体途径设计更安全的镇痛药
Trends Pharmacol Sci. 2017 Nov;38(11):1016-1037. doi: 10.1016/j.tips.2017.08.004. Epub 2017 Sep 19.
7
Digital Pills to Measure Opioid Ingestion Patterns in Emergency Department Patients With Acute Fracture Pain: A Pilot Study.用于测量急性骨折疼痛急诊科患者阿片类药物摄入模式的数字药丸：一项试点研究。
J Med Internet Res. 2017 Jan 13;19(1):e19. doi: 10.2196/jmir.7050.
8
Taking the Bait from the Prescription Opioid Industry: a Mea Culpa.受处方阿片类药物行业蛊惑：一份认罪书。
J Gen Intern Med. 2022 Jun;37(8):2072-2073. doi: 10.1007/s11606-021-07381-5. Epub 2022 Jan 19.
9
Predictors of shortages of opioid analgesics in the US: Are the characteristics of the drug company the missing puzzle piece?美国阿片类镇痛药短缺的预测因素：制药公司的特征是否是缺失的关键？
PLoS One. 2021 Mar 31;16(3):e0249274. doi: 10.1371/journal.pone.0249274. eCollection 2021.
10
Use of Opioid Analgesics in Older Australians.澳大利亚老年人使用阿片类镇痛药的情况。
Pain Med. 2015 Aug;16(8):1519-27. doi: 10.1111/pme.12720. Epub 2015 Feb 26.
引用本文的文献
1
What did the scientific literature learn from internal company documents in the pharmaceutical industry? A scoping review.科学文献从制药行业的公司内部文件中学到了什么？一项范围综述。
Cochrane Evid Synth Methods. 2023 Apr 27;1(3):e12011. doi: 10.1002/cesm.12011. eCollection 2023 May.
2
Pharmaceutical industry use of key opinion leaders to market prescription opioids: A review of internal industry documents.制药行业利用关键意见领袖推销处方阿片类药物：行业内部文件综述
Explor Res Clin Soc Pharm. 2024 Nov 19;16:100543. doi: 10.1016/j.rcsop.2024.100543. eCollection 2024 Dec.
3
The opioid industry's use of scientific evidence to advance claims about prescription opioid safety and effectiveness.阿片类药物行业利用科学证据来推进有关处方阿片类药物安全性和有效性的主张。
Health Aff Sch. 2024 Oct 24;2(10):qxae119. doi: 10.1093/haschl/qxae119. eCollection 2024 Oct.
4
Evaluation of the strategies opioid manufacturers used to recruit health professionals and encourage overprescribing: an analysis of industry documents.阿片类药物制造商用于招募医疗专业人员并鼓励过度开药的策略评估：行业文件分析
BMC Public Health. 2024 Aug 8;24(1):2153. doi: 10.1186/s12889-024-19642-z.
5
Promoting opioids, a story about how to influence medical science and opinions.推广阿片类药物，一个关于如何影响医学科学和观点的故事。
Front Med (Lausanne). 2024 Apr 26;11:1327939. doi: 10.3389/fmed.2024.1327939. eCollection 2024.
6
Telling the story of the opioid crisis: A narrative analysis of the TV series Dopesick.讲述阿片类危机的故事：电视剧《成瘾剂量》的叙事分析。
PLoS One. 2024 Apr 4;19(4):e0301681. doi: 10.1371/journal.pone.0301681. eCollection 2024.
7
Retail chain pharmacy opioid dispensing practices from 1997 to 2020: A content analysis of internal industry documents.1997年至2020年零售连锁药店阿片类药物配药实践：行业内部文件的内容分析
Drug Alcohol Depend Rep. 2023 Nov 2;9:100199. doi: 10.1016/j.dadr.2023.100199. eCollection 2023 Dec.
本文引用的文献
1
Marketing Opioids to Veterans and Older Adults: A Content Analysis of Internal Industry Documents Released from State of Oklahoma v. Purdue Pharma LP, et al.向退伍军人和老年人推销阿片类药物：从俄克拉荷马州诉普渡制药公司等案中发布的内部行业文件的内容分析
J Health Polit Policy Law. 2022 Aug 1;47(4):453-472. doi: 10.1215/03616878-9716712.
2
The Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms.不断演变的过量用药流行趋势：合成阿片类药物与兴奋剂相关危害的增加
Epidemiol Rev. 2020 Jan 31;42(1):154-166. doi: 10.1093/epirev/mxaa011.
3
Bringing the commercial determinants of health out of the shadows: a review of how the commercial determinants are represented in conceptual frameworks.将健康的商业决定因素从阴影中带出来：对商业决定因素在概念框架中如何呈现的综述。
Eur J Public Health. 2020 Aug 1;30(4):660-664. doi: 10.1093/eurpub/ckz197.
4
Distract, delay, disrupt: examples of manufactured doubt from five industries.转移、拖延、扰乱：五个行业制造质疑的例子。
Rev Environ Health. 2019 Dec 18;34(4):349-363. doi: 10.1515/reveh-2019-0004.
5
Civil Litigation and the Opioid Epidemic: The Role of Courts in a National Health Crisis.民事诉讼与阿片类药物泛滥：法院在国家卫生危机中的作用。
J Law Med Ethics. 2018 Jun;46(2):351-366. doi: 10.1177/1073110518782945.
6
The commercial determinants of health.健康的商业决定因素。
Lancet Glob Health. 2016 Dec;4(12):e895-e896. doi: 10.1016/S2214-109X(16)30217-0.
7
Is the Prescription Opioid Epidemic a White Problem?处方阿片类药物流行是白人的问题吗？
Am J Public Health. 2016 Dec;106(12):2127-2129. doi: 10.2105/AJPH.2016.303483.
Zotero 插件